Published in Law and Health Weekly, March 27th, 2004
The first implant in the trial was conducted by Charles O'Shaughnessy, MD, Elyria Memorial Hospital, Elyria, Ohio, on February 19, 2004. Endeavor III is a clinical trial evaluating the safety and efficacy of the investigational Endeavor Drug Eluting Coronary Stent and is being conducted at 30 sites in the United States.
"We are pleased to be a part of this pivotal study, as the potential of having the Driver stent combined with a drug and polymer to evaluate restenosis and event rates is very important for our patients," said O'Shaughnessy, an expert...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.